Botulinum Neurotoxin Type A quantitative test
Botulinum Neurotoxin Type A quantitative test
The Botulinum Neurotoxin Type A quantitative test is a highly optimized analytical assay specifically engineered to measure Botulinum Neurotoxin Type A (BoNT-A) concentrations with accuracy and reproducibility. Leveraging a one-step ELISA format, this test simplifies the traditionally complex detection process by integrating sample addition and detection into a streamlined protocol. This innovation ensures consistent and reliable quantification of BoNT-A levels, which is crucial for supporting toxin research. The test’s optimized design reduces variability and improves throughput, making it ideal for laboratories that demand dependable quantitative data.
Botulinum Neurotoxin Type A, a potent zinc protease produced by Clostridium botulinum, poses a significant health risk due to its ability to block acetylcholine release at neuromuscular junctions, leading to paralysis and potentially fatal botulism. Given its potency and relevance in both medical and environmental contexts, accurate quantification of BoNT-A is essential. This assay utilizes a sensitive sandwich ELISA method, where BoNT-A-specific monoclonal antibodies capture and detect the target toxin. The assay’s detection range of 46.9 to 3000 pg/mL enables precise measurements across a broad concentration spectrum, facilitating comparative studies and surveillance of naturally occurring or experimental BoNT-A in biological samples.
Tribioscience’s test kit provides an advanced solution for laboratories needing high-performance tools to support toxin-related studies. By using a monoclonal antibody-based platform pre-coated onto microplates and employing biotin-streptavidin-HRP chemistry with an ultra-sensitive TMB substrate, the assay delivers high signal clarity and minimal background interference. The result is an assay that offers not only speed and simplicity but also the sensitivity required for accurate BoNT-A detection in complex sample matrices such as serum and plasma. For labs engaged in BoNT-A research, diagnostics, or safety monitoring, this quantitative test offers a balance of precision, ease of use, and reproducibility.
